NORTHWEST BIOTHERAPEUTICS INC
Clinical trial NCT04060303 updates: 1. completion date: 2024-06-30 → 2024-11-06 2. primary completion date: 2024-06-30 → 2024-11-06 3. enrollment: 599 → 597 participants
Clinical trial NCT04060303 updates: 1. completion date: 2024-06-30 → 2024-11-06 2. primary completion date: 2024-06-30 → 2024-11-06 3. enrollment: 599 → 597 participants
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical